4Accepted Oct 7, 9:35 PM ET
Palisade Bio: president & CMO Jones M. Lawrence exercised 2,620,850 shares
Accepted (ET)
9:35 PM
Oct 7, 2026
Filed
Oct 7, 2026
Documents
1
Size
12.1 KB
Summary
Palisade Bio: president & CMO Jones M. Lawrence exercised 2,620,850 shares
What happened
- Jones Mitchell Lawrence, president & chief medical officer, exercised or converted RSUs totaling 2,620,850 shares on Oct 6, 2026, the filing says. The filing shows 1,031,102 shares were withheld to satisfy income tax withholding at $1.49 per share for $1,536,342. The filing also lists derivative conversion/disposition entries for 2,555,266 shares and 65,584 shares at $0.00.
Key details
- Transaction date: Oct 6, 2026. Tax withholding price: $1.49 per share; withholding value: $1,536,342.
- Shares acquired by exercise/conversion: 2,620,850 shares (per filing). Shares withheld for taxes: 1,031,102 shares.
- Shares owned after the transaction: not stated in the filing.
- Relevant footnotes from the filing:
- F1: Shares were issued pursuant to settlement of vested restricted stock units (RSUs).
- F2: 1,031,102 shares were withheld to satisfy income tax withholding and will not be sold in the public market.
- F3: Each RSU represents a contingent right to receive one share of common stock.
- F4: One RSU award vests 1/3rd on Oct 6, 2026 and quarterly thereafter over the following 8 quarters, subject to continuous service.
- F5: Another RSU award vests 1/6th on Jul 6, 2026 and quarterly thereafter over the following 10 quarters, subject to continuous service.
- Filing date and timeliness: filed Oct 7, 2026 for a report period of Oct 6, 2026 (no late filing indicated in the filing).
Why it may matter
- The filing shows settlement of vested RSUs with shares withheld to cover tax obligations, which is a non-market settlement method rather than an open-market sale. The filing does not show why the insider traded or why the company acted.